From October 1, 2022 to December 31, 2022, the company has repurchased 540,000 shares, representing 0.1% for CNY 2.7 million. With this, the company has completed the repurchase of 7,198,500 shares, representing 1.28% for CNY 37.65 million under the buyback announced on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.78 CNY | -2.05% | -5.72% | -22.02% |
1st Jan change | Capi. | |
---|---|---|
-22.02% | 368M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.17% | 238B | |
+7.05% | 204B | |
-6.42% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.